Objective: Little is known about the experiences, values and needs of people without arthritis who undergo predictive biomarker testing for the development of rheumatoid arthritis (RA). Our study aimed to explore the perspectives of these individuals and describe their information needs. Methods: A qualitative, multicenter interview study with a thematic analysis was conducted in Austria, Germany and the UK. Individuals who underwent predictive biomarker testing for RA and had a positive test result, but no diagnosis of any inflammatory joint disease, were interviewed. Participants included patients with arthralgia and asymptomatic individuals. Information and education needs were developed from the qualitative codes and themes using t...
Introduction: Currently, ther...
Treating patients with rheumatoid arthritis (RA) within three months of symptom onset 2 leads to sig...
Abstract Background There is increasing research interest in the development of preventive treatment...
Objective Little is known about the experiences, values, and needs of people without arthritis who ...
Background: There is increasing research focus on prediction and prevention of rheumatoid arthritis...
Background: There is growing evidence that it may be possible to identify people at...
OBJECTIVES: There is increasing interest in prediction and prevention of rheumatoid arthritis (RA). ...
Objectives: There is increasing interest in prediction and prevention of RA. It is important to und...
Objectives There is increasing interest in identifying individuals at-risk of rheumatoid arthritis (...
Background: There is increasing interest in the identification of people at risk of rheumatoid arthr...
Background: There is increasing research interest in the development of preventive treatment for ind...
Objectives: The family members of patients with rheumatoid arthritis (RA) are at increased risk of ...
Objective: Some immunomodulatory drugs have been shown to delay the onset of, or lower the risk of d...
Treating patients with rheumatoid arthritis (RA) within three months of symptom onset leads to signi...
Objectives: To understand the perspectives of patients with rheumatoid arthritis (RA) about the risk...
Introduction: Currently, ther...
Treating patients with rheumatoid arthritis (RA) within three months of symptom onset 2 leads to sig...
Abstract Background There is increasing research interest in the development of preventive treatment...
Objective Little is known about the experiences, values, and needs of people without arthritis who ...
Background: There is increasing research focus on prediction and prevention of rheumatoid arthritis...
Background: There is growing evidence that it may be possible to identify people at...
OBJECTIVES: There is increasing interest in prediction and prevention of rheumatoid arthritis (RA). ...
Objectives: There is increasing interest in prediction and prevention of RA. It is important to und...
Objectives There is increasing interest in identifying individuals at-risk of rheumatoid arthritis (...
Background: There is increasing interest in the identification of people at risk of rheumatoid arthr...
Background: There is increasing research interest in the development of preventive treatment for ind...
Objectives: The family members of patients with rheumatoid arthritis (RA) are at increased risk of ...
Objective: Some immunomodulatory drugs have been shown to delay the onset of, or lower the risk of d...
Treating patients with rheumatoid arthritis (RA) within three months of symptom onset leads to signi...
Objectives: To understand the perspectives of patients with rheumatoid arthritis (RA) about the risk...
Introduction: Currently, ther...
Treating patients with rheumatoid arthritis (RA) within three months of symptom onset 2 leads to sig...
Abstract Background There is increasing research interest in the development of preventive treatment...